{"schema_version":"1","generated_at":"2026-11-03T09:25:52.138Z","data_as_of":null,"url":"https://www.findmykol.com/kol/edus-warren","json_url":"https://www.findmykol.com/kol/edus-warren/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"edus-warren","name":"Edus Warren","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Washington","institution_url":"https://www.findmykol.com/institution/university-of-washington","city":"Seattle","state":"WA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1013092840","orcid":"0000-0002-9570-2755","openalex":"A5064080252"},"summary":"Edus Warren is an Oncology physician affiliated with University of Washington. OpenAlex indexes 257 publications with 10,148 citations (h-index 51); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":257,"cited_by_count":10148,"h_index":51,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00107354","title":"Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Fred Hutchinson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT00107354","trial_url":"https://www.findmykol.com/trial/NCT00107354"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"ROCHE MOLECULAR SYSTEMS, INC.","program_year":2024,"amount_usd":3424.26,"payment_count":9,"source_url":"https://openpaymentsdata.cms.gov/search?query=1013092840"},{"payer":"Epizyme, Inc.,","program_year":2021,"amount_usd":11.5,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1013092840"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1013092840","source":"payments"},"prescribing":{"data_year":2022,"areas_total":2,"areas_shown":2,"areas":[{"area":"Dermatology","share_pct":65.1,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":65.1,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":34.9,"classes_total":1,"classes":[{"class":"Short-acting sulfonamides","setting":"prescribed","share_pct":34.9,"drugs":[{"name":"Sulfamethoxazole-Trimethoprim","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2022,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":10,"fiscal_years":{"first":1999,"last":2026},"rows_total":39,"shown":3,"withheld":36,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"U01CA295053","title":"Comprehensive Characterization of the T-cell Response to KSHV to Enable Specific Immune Therapy","fiscal_year":2026,"amount_usd":"161920","organization":"FRED HUTCHINSON CANCER CENTER","source_url":"https://reporter.nih.gov/quickSearch/U01CA295053"},{"project":"U01CA295053","title":"Comprehensive Characterization of the T-cell Response to KSHV to Enable Specific Immune Therapy","fiscal_year":2025,"amount_usd":"4234248","organization":"FRED HUTCHINSON CANCER CENTER","source_url":"https://reporter.nih.gov/quickSearch/U01CA295053"},{"project":"R21CA302296","title":"HIV persistence and treatment response in Kaposi sarcoma","fiscal_year":2025,"amount_usd":"432098","organization":"FRED HUTCHINSON CANCER CENTER","source_url":"https://reporter.nih.gov/quickSearch/R21CA302296"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Precision Medicine in Low- and Middle-Income Countries","year":2022,"journal":"Annual Review of Pathology Mechanisms of Disease","source_url":"https://doi.org/10.1146/annurev-pathol-042320-034052","status":"verified"},{"title":"Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study","year":2021,"journal":"The Lancet Haematology","source_url":"https://doi.org/10.1016/s2352-3026(21)00170-8","status":"verified"},{"title":"Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy","year":2019,"journal":"American Journal of Hematology","source_url":"https://doi.org/10.1002/ajh.25505","status":"verified"},{"title":"A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure","year":2018,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-17-3763","status":"verified"},{"title":"Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation","year":2017,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2016-10-743294","status":"verified"}],"source":"works"},"contact":{"address_1":"UNIVERSITY OF WASHINGTON MEDICAL CTR","address_2":"1959 NE PACIFIC ST","city":"Seattle","state":"WA","zip":"981950001","phone":"206-288-1000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1013092840","source":"identity"},"similar":[{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Connie Celum","slug":"connie-celum","institution":"University of Washington","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/connie-celum","json_url":"https://www.findmykol.com/kol/connie-celum/profile.json"},{"name":"Helen Chu","slug":"helen-chu","institution":"University of Washington","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/helen-chu","json_url":"https://www.findmykol.com/kol/helen-chu/profile.json"},{"name":"Bryan Kestenbaum","slug":"bryan-kestenbaum","institution":"University of Washington","specialty":"Nephrology","url":"https://www.findmykol.com/kol/bryan-kestenbaum","json_url":"https://www.findmykol.com/kol/bryan-kestenbaum/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":36,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2013-01-28","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}